-

SynergenX Network Clinics Launch 2026 New Year, Healthy You Campaign

HOUSTON--(BUSINESS WIRE)--SynergenX, the veteran-owned leader in provider-led, personalized hormone and wellness medicine, is launching a bold New Year 2026 campaign designed to make hormone testing, wellness care, and medical weight loss more accessible across the SynergenX network clinics, including Low T Center and HerKare.

Built around the belief that better healthcare starts with access, the initiative brings together comprehensive testing, board-certified provider consultations, and intentionally designed pricing to help communities move toward better health with confidence.

“Modern healthcare should be designed around patient-focused outcomes,” said Wayne Wilson, Founder and CEO of SynergenX. “This initiative reflects our belief that medically guided care should be accessible, personalized, and built to help patients meaningfully improve their health and quality of life.”

January 2026 Offers Include:

  • FREE men’s testosterone testing, available at SynergenX and Low T Center clinics, applied to the initial qualifying testosterone lab used to assess whether testosterone levels may be contributing to symptoms.
  • Women’s complete hormone testing for $99 self-pay. Available at SynergenX, Low T Center, and HerKare clinics. The visit includes a comprehensive hormone panel measuring 67+ biomarkers, an InBody body composition scan (where available), an Autonomic Nervous System (ANS) test, and a provider consultation. Insurance patients pay only their copay, while deductible patients have costs applied toward their deductible. Women who qualify for low-dose testosterone therapy may receive their first injection included when administered at that appointment.
  • Free Weight Loss Consultation available at SynergenX, Low T Center, and HerKare clinics. When they book a weight loss appointment, patients can choose between a free, detailed weight loss consultation with a provider, or an extensive weight loss examination including an Autonomic Nervous system testing and InBody scanning (where available) to tailor each patient’s ultimate weight loss plan.
  • $50 off per vial of GLP-1 weight loss medications and additional treatments, available at SynergenX, Low T Center, and HerKare clinics. Due to competitive pricing, Sermorelin is $10 off per vial during the campaign.

The initiative reflects SynergenX’s groundbreaking, provider-led, patient-focused model, and its continued national expansion.

Appointments are limited. To learn more or schedule a visit, go to SynergenXHealth.com.

Contacts

Media Contact:
Jordan Bailey
Marketing Communications Specialist, SynergenX / Low T Center
8326391569
jbailey@synergenxhealth.com

SynergenX


Release Versions

Contacts

Media Contact:
Jordan Bailey
Marketing Communications Specialist, SynergenX / Low T Center
8326391569
jbailey@synergenxhealth.com

More News From SynergenX

SynergenX Network Clinics Expand Peptide Therapy Options with BPC-157 and CJC-1295 + Ipamorelin

HOUSTON--(BUSINESS WIRE)--SynergenX, veteran-owned leader in personalized hormone and wellness medicine, is expanding its peptide therapy program with the addition of BPC-157 and CJC-1295 + Ipamorelin, two popular new peptide therapies that allow patients to pursue natural, rejuvenating option for health optimization, alone or in addition to hormone and weight-loss therapies. Beginning October 6, 2025, patients across SynergenX, Low T Center, and HerKare locations will have access to these adva...

SynergenX Opens Testosterone Cypionate Therapy to Female Patients

HOUSTON--(BUSINESS WIRE)--SynergenX, national leader in customized hormone optimization, prescription weight loss, and medically supervised wellness, is expanding its hormone replacement therapy (HRT) services for women to include injections of testosterone cypionate. Beginning July 28, 2025, these services will be available at all locations nationwide. This expansion marks the first time that female patients can access the custom-dosed testosterone cypionate injections available to male patien...

Low T Center Launches Women’s Hormone Health Services Nationwide

HOUSTON--(BUSINESS WIRE)--Low T Center, leader in personalized hormone optimization, is expanding its hormone care services to include women’s hormone replacement therapy (HRT), including in-clinic and self-inject testosterone replacement therapy. Beginning July 28, 2025, these services will be available at all clinic locations nationwide. This expansion advances the accessibility of hormone care for women, reflecting a continued investment in precision medicine, clinical oversight, and individ...
Back to Newsroom